cycloheximide has been researched along with cks 17 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nelson, D; Nelson, M | 1 |
| Cianciolo, GJ; Day, NK; Good, RA; Haraguchi, S; James-Yarish, M | 1 |
2 other study(ies) available for cycloheximide and cks 17
| Article | Year |
|---|---|
Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide.
Topics: Animals; Cell Division; Concanavalin A; Cycloheximide; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-2; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Neoplasm Proteins; Peptides; Receptors, Interleukin-2; Retroviridae Proteins, Oncogenic; RNA, Messenger; Suppressor Factors, Immunologic; Tumor Cells, Cultured; Viral Envelope Proteins | 1990 |
Transcriptional down-regulation of tumor necrosis factor-alpha gene expression by a synthetic peptide homologous to retroviral envelope protein.
Topics: Amino Acid Sequence; Cycloheximide; Down-Regulation; Enterotoxins; Gene Expression Regulation; Humans; Indomethacin; Intercellular Signaling Peptides and Proteins; Interleukin-1; Molecular Sequence Data; Peptides; Retroviridae Proteins, Oncogenic; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Viral Envelope Proteins | 1993 |